Cargando…
Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis
Tumor-specific overexpression of receptors enables a variety of targeted cancer therapies, exemplified by peptide-receptor radiotherapy (PRRT) for somatostatin receptor (SSTR)-positive neuroendocrine tumors. While effective, PRRT is restricted to tumors with SSTR overexpression. To overcome this lim...
Autores principales: | Ottolino-Perry, Kathryn, Mealiea, David, Sellers, Clara, Acuna, Sergio A., Angarita, Fernando A., Okamoto, Lili, Scollard, Deborah, Ginj, Mihaela, Reilly, Raymond, McCart, J. Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173076/ https://www.ncbi.nlm.nih.gov/pubmed/37180034 http://dx.doi.org/10.1016/j.omto.2023.04.001 |
Ejemplares similares
-
Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021) -
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer
por: Lee, Yu Seong, et al.
Publicado: (2020) -
Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis
por: Akce, Mehmet, et al.
Publicado: (2014) -
Peritoneal carcinomatosis mimicking a peritoneal tuberculosis
por: Jung, Eun Young, et al.
Publicado: (2015) -
CT mimics of peritoneal carcinomatosis
por: Smiti, S, et al.
Publicado: (2010)